| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.054 | 0.4 |